Recent Advances in Prenatal Diagnosis and Fetal Therapy

Dear Colleagues,

Obstetrics, gynecology, and fetal medicine have seen remarkable progress with the advent of Next-Generation Sequencing (NGS) and advanced 3D imaging techniques, enabling noninvasive prenatal testing and detailed virtual models of fetal anatomy. These advancements are pivotal in the context of personalized medicine, offering tailored diagnostic and therapeutic options.

This Special Issue aims to explore recent advances in prenatal diagnosis and fetal therapy, emphasizing the integration of cutting-edge technologies and personalized approaches. We aim to showcase research that improves our understanding and management of fetal diseases, ultimately benefiting both mothers and their unborn children through more precise and individualized treatments.

We invite the submission of original research articles, review papers, and clinical trials, among other types of papers, focused on the use of novel methodologies for prenatal diagnosis, innovative fetal therapies, and patient experiences. Particular emphasis is placed on contributions that demonstrate the application of personalized medicine in prenatal and fetal care. Your contributions will help advance our knowledge and improve clinical practices in this vital area of medicine.

I look forward to receiving your submissions and working together to enhance prenatal diagnosis and fetal therapy through the lens of personalized medicine.

Prof. Dr. Gabrielle Tonni
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.